DongKoo Bio&Pharma Co. Ltd (KQ:006620) — Stock Price

₩3990.00 KRW
▲ 2.31% today

DongKoo Bio&Pharma Co. Ltd (KQ:006620) is currently trading at ₩3990.00 KRW, up 2.31% today. Over the past 52 weeks, shares have ranged between ₩3505.00 and ₩6090.00. This page tracks DongKoo Bio&Pharma Co. Ltd's live share price on the KQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see DongKoo Bio&Pharma Co. Ltd stock valuation.

DongKoo Bio&Pharma Co. Ltd (006620) Stock Price Chart — Daily History & Trading Volume

The chart below tracks DongKoo Bio&Pharma Co. Ltd's daily closing share price and trading volume on the KQ exchange over the past year, giving a clear view of recent price momentum and liquidity.

DongKoo Bio&Pharma Co. Ltd Income Statement — Revenue, Profit & Earnings by Year

DongKoo Bio&Pharma Co. Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20242023202220212020
Total Revenue ₩249.27 Billion ₩215.69 Billion ₩194.99 Billion ₩155.15 Billion ₩139.22 Billion
Cost of Revenue ₩97.25 Billion ₩83.49 Billion ₩77.01 Billion ₩62.71 Billion ₩58.60 Billion
Gross Profit ₩152.03 Billion ₩132.19 Billion ₩117.98 Billion ₩92.44 Billion ₩80.62 Billion
Research & Development ₩8.38 Billion ₩10.75 Billion ₩8.26 Billion ₩10.11 Billion ₩10.75 Billion
SG&A ₩130.04 Billion ₩105.94 Billion ₩91.83 Billion ₩73.48 Billion ₩61.71 Billion
Total Operating Expenses ₩236.58 Billion ₩201.07 Billion ₩177.95 Billion ₩147.01 Billion ₩131.60 Billion
Operating Income ₩12.37 Billion ₩14.61 Billion ₩17.04 Billion ₩8.14 Billion ₩7.62 Billion
EBITDA — — — — —
EBIT — — — ₩8.14 Billion ₩7.61 Billion
Interest Expense ₩2.89 Billion ₩1.76 Billion ₩1.04 Billion ₩415.63 Million ₩430.83 Million
Income Before Tax ₩3.82 Billion ₩14.74 Billion ₩7.92 Billion ₩11.33 Billion ₩10.30 Billion
Income Tax Expense — — — ₩2.01 Billion ₩1.16 Billion
Net Income ₩2.04 Billion ₩11.81 Billion ₩6.61 Billion ₩9.33 Billion ₩9.14 Billion

DongKoo Bio&Pharma Co. Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes DongKoo Bio&Pharma Co. Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20242023202220212020
Total Assets ₩244.06 Billion ₩191.10 Billion ₩172.06 Billion ₩154.79 Billion ₩144.35 Billion
Total Current Assets ₩107.24 Billion ₩88.36 Billion ₩87.42 Billion ₩73.83 Billion ₩72.35 Billion
Cash & Equivalents ₩25.37 Billion ₩15.71 Billion ₩12.51 Billion ₩19.56 Billion ₩4.88 Billion
Short-term Investments ₩10.87 Billion ₩7.19 Billion ₩22.27 Billion ₩12.40 Billion ₩24.63 Billion
Net Receivables ₩19.91 Billion ₩19.88 Billion ₩18.50 Billion ₩15.76 Billion ₩17.59 Billion
Inventory ₩45.96 Billion ₩42.61 Billion ₩31.43 Billion ₩24.96 Billion ₩24.97 Billion
Property, Plant & Equipment ₩66.22 Billion ₩50.48 Billion ₩39.68 Billion ₩40.05 Billion ₩40.38 Billion
Goodwill — — — — —
Total Liabilities ₩138.73 Billion ₩80.66 Billion ₩69.95 Billion ₩54.66 Billion ₩49.70 Billion
Total Current Liabilities ₩115.25 Billion ₩73.32 Billion ₩66.04 Billion ₩50.02 Billion ₩40.51 Billion
Long-term Debt ₩10.47 Billion ₩1.45 Billion ₩0.00 ₩0.00 ₩5.00 Billion
Net Debt ₩59.97 Billion ₩26.23 Billion ₩20.49 Billion ₩3.51 Billion ₩18.12 Billion
Total Stockholder Equity ₩105.33 Billion ₩110.40 Billion ₩102.11 Billion ₩100.12 Billion ₩94.65 Billion
Retained Earnings ₩67.32 Billion ₩69.74 Billion ₩61.67 Billion ₩57.16 Billion ₩49.73 Billion

DongKoo Bio&Pharma Co. Ltd Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how DongKoo Bio&Pharma Co. Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20242023202220212020
Operating Cash Flow ₩17.34 Billion ₩3.59 Billion ₩16.82 Billion ₩17.90 Billion ₩7.49 Billion
Capital Expenditures ₩25.46 Billion ₩15.97 Billion ₩11.08 Billion ₩4.27 Billion ₩5.27 Billion
Free Cash Flow ₩-8.12 Billion ₩-12.38 Billion ₩5.74 Billion ₩12.43 Billion ₩2.03 Billion
Investing Cash Flow ₩-45.03 Billion ₩-5.13 Billion ₩-27.01 Billion ₩463.93 Million ₩-12.56 Billion
Financing Cash Flow ₩37.19 Billion ₩4.75 Billion ₩3.19 Billion ₩-3.69 Billion ₩-361.45 Million
Dividends Paid ₩3.31 Billion ₩3.04 Billion ₩2.80 Billion ₩942.94 Million ₩942.92 Million
Stock-Based Compensation ₩251.89 Million ₩224.51 Million — — —
Depreciation ₩6.31 Billion ₩5.88 Billion ₩5.49 Billion ₩5.05 Billion ₩4.51 Billion
Change in Cash ₩9.66 Billion ₩3.20 Billion ₩-7.04 Billion ₩14.68 Billion ₩-5.46 Billion

DongKoo Bio&Pharma Co. Ltd Earnings History — EPS Actual vs. Analyst Estimates

Track DongKoo Bio&Pharma Co. Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 13, 2026 — — —
Mar 16, 2026 — — —
Nov 12, 2025 -59.72 — —
Aug 12, 2025 397.64 — —
May 15, 2025 -25.18 — —
Mar 18, 2025 -304.28 — —
Nov 12, 2024 131.36 — —
Aug 14, 2024 83.31 — —